PHARMACY-PRICE DISCLOSURE Senate SponsorsSen. Andy Manar-Melinda Bush 1/13/2021SenateSession Sine Die 225 ILCS 85/43 newAmends the Pharmacy Practice Act. Provides that a pharmacist or his or her authorized employee must disclose to the consumer at the point of sale the current pharmacy retail price for each prescription medication the consumer intends to purchase. If the consumer's cost-sharing amount for a prescription exceeds the current pharmacy retail price, the pharmacist or his or her authorized employee must disclose to the consumer that the pharmacy retail price is less than the patient's cost-sharing amount. Defines terms. Effective immediately. 2/11/2020SenateFiled with Secretary by Sen. Andy Manar 2/11/2020SenateFirst Reading 2/11/2020SenateReferred to Assignments 2/18/2020SenateAdded as Chief Co-Sponsor Sen. Melinda Bush 2/19/2020SenateAssigned to Licensed Activities 3/18/2020SenateRule 2-10 Committee Deadline Established As April 2, 2020 3/25/2020SenateRule 2-10 Committee Deadline Established As April 24, 2020 3/25/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 7, 2020 4/12/2020SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 4/16/2020SenateRule 2-10 Committee Deadline Established As April 30, 2020 4/23/2020SenateRule 2-10 Committee Deadline Established As May 7, 2020 4/23/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Committee Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Committee Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 29, 2020 5/15/2020SenateRule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020 1/13/2021SenateSession Sine Die